Edem Agamah, MD

Edem Agamah, MD

Oncologist, Hematologist
Internal Medicine | Hematology-Oncology
Accepting new patients
Call for an appointment
217-545-8000
or
Request appointment
Languages:
English, Ewe

    About me

    Specializes in:

    • Hematology
    • Oncology
    • Blood Disorders

     

    Gender

    Male

    Additional languages spoken

    Ewe

    Education & training

    Positions
    Professor
    Board Certifications
    Medical Oncology
    Internal Medicine
    Medical School
    University of Ghana Medical School, Accra, Ghana
    Residency
    Korle Bu Teaching Hospital, Accra, Ghana - Hematology, St. Francis Hospital, Evanston, IL - Internal Medicine
    Fellowship
    University of Chicago, Chicago, IL - Hematology/Oncology

    Specialties

    Conditions

    Patients in waiting room

    Appointments

    SIU Medicine strongly encourages all patients to verify coverage, benefits and which providers are considered in-network with their health plan. SIU Medicine has more than 300 health care providers ready to serve you and your family. SIU Medicine accepts a wide variety of governmental and non-governmental health plans to serve our community. 

    Clinical locations

    Locations

    SIU Medicine Cancer Care | Springfield

    315 W. Carpenter St. Springfield, IL 62702 1st Floor, Clinic B
    Get Directions
    Mon - Fri: 8:00 am-4:30 pm
    Locations

    SIU Medicine Cancer Care | Jacksonville

    1600 W. Walnut St. Jacksonville, IL 62650 2nd Floor, East Bldg
    Get Directions
    Mon - Fri: 8:00 am-4:30 pm
    217-545-8000

    Hospital privileges

    • HSHS St. Francis Hospital, Litchfield IL
    • HSHS St. John's Hospital, Springfield, IL
    • Jacksonville Memorial Hospital, Jacksonville, IL
    • Memorial Health, Springfield IL

    Research

    Research Interests
    Genetic Epidemiology, Breast Cancer and Colon Cancer

    Featured Publications

    [1] Cozzens JW.  Drewes NB.  Delfino KR.  Chin KL.  Amin DV.  Lokaitis BC.  Espinosa JA.  Jones BA.  Acakpo-Satchivi LJ.  Dayoub H.  Frankel MB.  Agamah E.  Rao K.  Bradbury CM.  Gao J.  Age is not a significant predictor of survival in patients with IDH-wildtype glioblastoma that undergo gross total resection and complete adjuvant chemoradiation.  2025 ;15():1657867. 
    PMID: 41001028

    [2] Karim NA.  Miao J.  Reckamp KL.  Gay CM.  Byers LA.  Zhao YQ.  Redman MW.  Carrizosa DR.  Wang WL.  Petty WJ.  Mehta K.  Faller BA.  Agamah ES.  Kasbari SS.  Malisetti RK.  Kumar A.  Schallenkamp J.  Alluri KC.  Gray JE.  Kelly K.  Phase II Randomized Study of Maintenance Atezolizumab Versus Atezolizumab Plus Talazoparib in Patients With SLFN11 Positive Extensive-Stage SCLC: S1929.  2025 Mar;20(3):383-394. 
    PMID: 39505259

    [3] Fizazi K.  Shore N.  Tammela TL.  Ulys A.  Vjaters E.  Polyakov S.  Jievaltas M.  Luz M.  Alekseev B.  Kuss I.  Kappeler C.  Snapir A.  Sarapohja T.  Smith MR.  .  Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer.  2019 Mar;380(13):1235-1246. 
    PMID: 30763142

    Read All Publications